BioXcel announces defense grant to UNC to fund study for treating acute stress disorder
seekingalpha
2024-10-15
BioXcel Therapeutics (NASDAQ:BTAI) announced a collaboration with the University of North Carolina at Chapel Hill on a grant awarded by the U.S. Department of Defense to evaluate the efficacy and safety of BXCL501 as a potential treatment for acute stress